Dax has the 16,000 point mark in focus again – Biontech share falls significantly according to new Omikron data

Dax curve

The leading German index has already reached several new record highs this year.

(Photo: Bloomberg Creative / Getty Images [M])

Dusseldorf The side effects of the new Omikron virus variant are apparently ticked off, and the focus on the German stock market is now on the year-end spurt. The next target is likely to be around 16,000 points, the upper limit of the sideways phase from early April to early November.

The Dax is not far away from that this Wednesday. In the first hour of trading, the German benchmark index is trading at 15,801 points, which is virtually unchanged. It should come as no surprise that the Frankfurt benchmark takes a breather after two successful trading days in a row. On Tuesday alone there was an increase of 2.8 percent to a final score of 15,814 points.

As a reminder: At the end of November, the focus was also on a round brand, but at that time it was 15,000 points. On November 30, the Dax slipped down to 15,015 positions. That shows how fast the market can turn.

Read on now

Get access to this and every other article in the

Web and in our app for 4 weeks free of charge.

Further

Read on now

Get access to this and every other article in the

Web and in our app for 4 weeks free of charge.

Further

.
source site-12